BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Harvard Business School
US Department of Justice

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075352

« Back to Dashboard

NDA 075352 describes SELEGILINE HYDROCHLORIDE, which is a drug marketed by Apotex, Dava Pharms Inc, Lannett Holdings Inc, Apotex Inc, Boscogen, Chartwell Molecules, G And W Labs Inc, Mylan, Siegfried, and Somerset, and is included in thirteen NDAs. It is available from seven suppliers. Additional details are available on the SELEGILINE HYDROCHLORIDE profile page.

The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.

Summary for 075352

Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 075352

Suppliers and Packaging for NDA: 075352

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 075352 ANDA Golden State Medical Supply, Inc. 60429-019 60429-019-60 60 CAPSULE in 1 BOTTLE (60429-019-60)
SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 075352 ANDA Par Pharmaceutical 67253-700 67253-700-06 60 CAPSULE in 1 BOTTLE (67253-700-06)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength5MG
Approval Date:Nov 30, 1998TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: